ibnlive » Chat

3 pm Apr 01, 2013

The significance of SC's denial of patent to Novartis for anti-cancer drug Glivec

In a landmark verdict, the Supreme Court dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving the way for more affordable life-saving cancer drugs. How does it affect the Indian pharmaceutical industry and the global biggies who are looking at India as a quick-growth market? Discuss the different aspects with one of India's foremost pharmaceutical industry experts.
This chat is over. Thanks for joining.
17 questions answered | No question pending
  • It's a very basic question but how can other developing countries such as china able to afford $2666 pm on this drug. Does this not affect their public health access Asked by: Tina
  • Vikas Dandekar China is in the middle of a massive healthcare reforms plan that aims to bring at least 90% population under insurance...In India, over 95% pays out-of-pocket
  • Is it more about affordability and less about not meeting the efficacy criteria? Asked by: Tina
  • Vikas Dandekar In fact - both....but the scope of Sec 3(d) was paramount.
  • Can they take India to WTO? Asked by: Tina
  • Vikas Dandekar WTO allows flexibilities in framing local laws...It will be tough to go to WTO on this issue.
  • What would happen now? What will be the impact on pharma industry esp foreign players who plan to invest in India? Asked by: Isha
  • Vikas Dandekar investments in the market will most likely continue...global investments in R&D has always been in question
  • Do you think MNC will hesitate to bring the latest molecules to india? Asked by: Deepak J Singh
  • Vikas Dandekar it depends...knowing the massive unmet medical need in India, I think MNCs will introduce drugs and make the pricing more relevant via tiered or differential pricing or good access programs
  • What is Glivec? Asked by: leena
  • Vikas Dandekar it is a drug used to treat a rare form of blood cancer...
  • Why is Novartis enforcing its patent on Glivec in India and in other in developing countries? Asked by: laxman
  • Vikas Dandekar here is the link to the case http://judis.nic.in/supremecourt/imgs1.aspx?filename=40212
  • What is the case all about? Asked by: Priya
  • Vikas Dandekar Just replied
  • Do you think this judgement if fair and right Asked by: Deepak J Singh
  • Vikas Dandekar Sorry sir, as media, I cant share personal views on a court verdict.
  • In terms of population the two large markets are India and China. Does Novartis hold patent for Glivec in China ? Asked by: sundar1950in
  • Vikas Dandekar yes, Glivec has patents in China...40 countries in total.
  • Will this verdict deny the nation of advanced medical benefits by MNC pharmaceuticals delaying or denying sale of their research products ?? Asked by: sundar1950in
  • Vikas Dandekar Don't think global companies will take any extreme step by this ruling
  • The significance of SC's denial of patent to Novartis for anti-cancer drug Glivec? Asked by: Priya
  • Vikas Dandekar it holds Sec 3(d) that disallows certain incremental innovations and evergreening of patents
  • For such an important case Six years of Litigation meant that many lives were lost in this period due to non affordability of the drug ? Was there a possibility to reduce the litigation period ? Asked by: sundar1950in
  • Vikas Dandekar an important question....India has taken a long time to close this vital case...for imatinib however there were generics available and Novartis has a patient access program...
  • How does it affect the Indian pharmaceutical industry and the global biggies who are looking at India as a quick-growth market? Asked by: Deepak
  • Vikas Dandekar Sec 3(d) is clearer now....new patents will be filed cautiously by MNCs...
  • When will the Indian Pharma industry get it's own research products to alleviate human sufferings.?Is there sufficient investments being made now ? Asked by: sundar1950in
  • Vikas Dandekar efforts are on for a very long time..Indian companies have made slow progress in researching new compounds but many new prospects are likely in the next few years.
  • Novartis has taken a hit at the Stock Market today. Will this affect the FDI and FII which our UPA needs badly ?? Asked by: sundar1950in
  • Vikas Dandekar don't think global companies will ignore the commercial attractiveness for Indian market....
  • Which are the Indian Pharma companies which will be now able to market the generic one of Glivec ? Asked by: sundar1950in
  • Vikas Dandekar i believe Ranbaxy, ciplam, sun and natco are in the market already...

Hosted by

Vikas Dandekar
Pharmaceutical industry expert